title: Evidence of recessive Alzheimer disease loci in a Caribbean Hispanic data set: genome-wide survey of runs of homozygosity.
abstract: IMPORTANCE The search for novel Alzheimer disease (AD) genes or pathologic mutations within known AD loci is ongoing. The development of array technologies has helped to identify rare recessive mutations among long runs of homozygosity (ROHs), in which both parental alleles are identical. Caribbean Hispanics are known to have an elevated risk for AD and tend to have large families with evidence of inbreeding. OBJECTIVE To test the hypothesis that the late-onset AD in a Caribbean Hispanic population might be explained in part by the homozygosity of unknown loci that could harbor recessive AD risk haplotypes or pathologic mutations. DESIGN We used genome-wide array data to identify ROHs (&gt;1 megabase) and conducted global burden and locus-specific ROH analyses. SETTING A whole-genome case-control ROH study. PARTICIPANTS A Caribbean Hispanic data set of 547 unrelated cases (48.8% with familial AD) and 542 controls collected from a population known to have a 3-fold higher risk of AD vs non-Hispanics in the same community. Based on a Structure program analysis, our data set consisted of African Hispanic (207 cases and 192 controls) and European Hispanic (329 cases and 326 controls) participants. EXPOSURE Alzheimer disease risk genes. MAIN OUTCOMES AND MEASURES We calculated the total and mean lengths of the ROHs per sample. Global burden measurements among autosomal chromosomes were investigated in cases vs controls. Pools of overlapping ROH segments (consensus regions) were identified, and the case to control ratio was calculated for each consensus region. We formulated the tested hypothesis before data collection. RESULTS In total, we identified 17 137 autosomal regions with ROHs. The mean length of the ROH per person was significantly greater in cases vs controls (P = .0039), and this association was stronger with familial AD (P = .0005). Among the European Hispanics, a consensus region at the EXOC4 locus was significantly associated with AD even after correction for multiple testing (empirical P value 1 [EMP1], .0001; EMP2, .002; 21 AD cases vs 2 controls). Among the African Hispanic subset, the most significant but nominal association was observed for CTNNA3, a well-known AD gene candidate (EMP1, .002; 10 AD cases vs 0 controls). CONCLUSIONS AND RELEVANCE Our results show that ROHs could significantly contribute to the etiology of AD. Future studies would require the analysis of larger, relatively inbred data sets that might reveal novel recessive AD genes. The next step is to conduct sequencing of top significant loci in a subset of samples with overlapping ROHs.
authors: Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.
authors: Mahdi
authors: M
authors: Ghani
authors: Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.
authors: Christine
authors: C
authors: Sato
authors: Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Gertrude H. Sergievsky Center, Departments of Neurology, Psychiatry, and Medicine, College of Physicians and Surgeons, Columbia University, New York, New York3Department of Epidemiolo.
authors: Joseph H
authors: JH
authors: Lee
authors: Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Gertrude H. Sergievsky Center, Departments of Neurology, Psychiatry, and Medicine, College of Physicians and Surgeons, Columbia University, New York, New York.
authors: Christiane
authors: C
authors: Reitz
authors: Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.
authors: Danielle
authors: D
authors: Moreno
authors: Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Gertrude H. Sergievsky Center, Departments of Neurology, Psychiatry, and Medicine, College of Physicians and Surgeons, Columbia University, New York, New York.
authors: Richard
authors: R
authors: Mayeux
authors: Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada4Department of Medicine, University of Toronto, Toronto, Ontario, Canada5Cambridge Institute for Medical Research and Department of Clinical Neuroscienc.
authors: Peter
authors: P
authors: St George-Hyslop
authors: Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada4Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
authors: Ekaterina
authors: E
authors: Rogaeva
mesh_terms: D017668:Age of Onset; D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000235:genetics*; D017691:Caribbean Region; D016022:Case-Control Studies; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D055106:Genome-Wide Association Study; D006630:Hispanic or Latino / Q000235:genetics; D006720:Homozygote; D006801:Humans; D008297:Male; D008562:Membrane Glycoproteins / Q000235:genetics; D020641:Polymorphism, Single Nucleotide; D033921:Vesicular Transport Proteins / Q000235:genetics
chemical_list: C486403:EMP2 protein, human; C489607:EXOC4 protein, human; D008562:Membrane Glycoproteins; D033921:Vesicular Transport Proteins
references: PLoS One. 2012;7(4):e34840
references: 22536334
references: Nat Genet. 2011 May;43(5):436-41
references: 21460841
references: Neurogenetics. 2009 Jul;10(3):183-90
references: 19271249
references: BMC Neurol. 2010 Oct 08;10:90
references: 20932310
references: Hum Mol Genet. 2006 Mar 1;15(5):789-95
references: 16436455
references: Science. 2009 Mar 13;323(5920):1473-7
references: 19286555
references: Am J Med Genet A. 2011 Apr;155A(4):757-68
references: 21594998
references: J Med Genet. 2007 Jan;44(1):e63
references: 17209133
references: Nat Cell Biol. 2003 Jun;5(6):520-30
references: 12738960
references: J Biol Chem. 2006 May 5;281(18):12352-61
references: 16527809
references: N Engl J Med. 2013 Jan 10;368(2):117-27
references: 23150934
references: Arch Neurol. 2012 Jan;69(1):59-64
references: 21911656
references: Arch Neurol. 2012 Dec;69(12):1583-90
references: 22964832
references: PLoS Genet. 2012;8(4):e1002656
references: 22511889
references: J Cell Biol. 2001 Feb 19;152(4):F17-20
references: 11266476
references: Nat Genet. 2011 May;43(5):429-35
references: 21460840
references: Nat Genet. 2009 Oct;41(10):1088-93
references: 19734902
references: Am J Med Genet A. 2012 Nov;158A(11):2935-40
references: 22987394
references: J Med Genet. 2005 Oct;42(10):787-92
references: 16199552
references: Science. 2000 Dec 22;290(5500):2304-5
references: 11125144
references: Genome Biol. 2011 Sep 28;12(9):R92
references: 21951382
references: Nat Cell Biol. 2010 Nov;12(11):1026-8
references: 21045801
references: Science. 2000 Dec 22;290(5500):2303-4
references: 11125143
references: Arch Neurol. 2010 Aug;67(8):961-4
references: 20554627
references: G3 (Bethesda). 2012 Jan;2(1):71-8
references: 22384383
references: Am J Hum Genet. 2007 Sep;81(3):626-33
references: 17701908
references: Clin Lab Med. 2011 Dec;31(4):595-613, ix
references: 22118739
references: Am J Hum Genet. 2011 Jan 7;88(1):76-82
references: 21167468
references: EMBO J. 2002 Apr 15;21(8):1948-56
references: 11953314
references: J Alzheimers Dis. 2011;23(2):349-59
references: 21098978
references: Hum Mol Genet. 2003 Dec 1;12(23):3133-43
references: 14559775
references: Hum Mol Genet. 2007 Dec 1;16(23):2854-69
references: 17761686
references: Biochem Biophys Res Commun. 1984 May 16;120(3):885-90
references: 6375662
references: JAMA. 2001 Nov 14;286(18):2257-63
references: 11710891
references: Neurobiol Aging. 2013 Jun;34(6):1712.e1-7
references: 23352322
references: Am J Med Genet B Neuropsychiatr Genet. 2011 Dec;156B(7):764-71
references: 21812096
references: Ann Hum Genet. 2008 Mar;72(Pt 2):261-78
references: 18205893
references: Mol Cell. 1999 Dec;4(6):893-902
references: 10635315
references: Neurobiol Aging. 2009 Dec;30(12):1986-91
references: 18387709
references: Bioinformatics. 2005 Jan 15;21(2):263-5
references: 15297300
references: Arch Neurol. 2011 Mar;68(3):320-8
references: 21059989
references: Mol Psychiatry. 2012 Dec;17(12):1340-6
references: 22005931
references: Arch Neurol. 2011 Dec;68(12):1569-79
references: 22159054
references: Hum Mutat. 2006 Nov;27(11):1115-21
references: 16955415
references: J Physiol Paris. 1998 Jun-Aug;92(3-4):289-92
references: 9789825
references: N Engl J Med. 2012 Jan 19;366(3):283-4
references: 22216764
references: BMC Genomics. 2011 Sep 23;12:460
references: 21943305
references: Arch Neurol. 2012 Jul;69(7):894-900
references: 22393166
references: Neurology. 2001 Jan 9;56(1):49-56
references: 11148235
references: PLoS One. 2010 Nov 15;5(11):e13996
references: 21085596
references: Nat Genet. 2007 Feb;39(2):168-77
references: 17220890
references: Genome Med. 2011 May 31;3(5):33
references: 21627779
references: Neurobiol Aging. 2012 Dec;33(12):2949.e5-2949.e12
references: 22819390
references: Nature. 2003 Apr 10;422(6932):629-33
references: 12687004
references: PLoS One. 2011;6(5):e20589
references: 21655227
references: Nat Genet. 2010 Jul;42(7):565-9
references: 20562875
references: PLoS One. 2008;3(12):e4080
references: 19114997
references: J Alzheimers Dis. 2006;9(3 Suppl):381-7
references: 16914876
references: Nat Genet. 2009 Oct;41(10):1094-9
references: 19734903
references: Nat Rev Mol Cell Biol. 2006 May;7(5):347-58
references: 16633337
references: PLoS One. 2009;4(1):e4172
references: 19137062
references: Hum Genet. 2012 Apr;131(4):565-79
references: 21996756
references: Genet Epidemiol. 2009 Feb;33(2):172-80
references: 18814273